Thus, rather than functioning as standalone predictive biomarkers, CLCA1, UGT2A3, and ZG16 are more likely mechanistic mediators linking bile acid metabolism to T-cell dysfunction in CRC. Here, ZG16 is linked to colorectal carcinoma.